Mike Moradi Details the Past, Present, and Future of Diabetes Care

Mike Moradi is a successful entrepreneur, having founded or been a principal in several nanotechnology and biopharmaceutical startups. He is a Co-Founder & CEO of Sensulin, LLC, a biopharmaceutical company that is developing the first true 24-hour glucose sensitive insulin for type I and type II diabetes. Mike was awarded a community service commendation from the United States Congress for his voluntary efforts in technology-based economic development. He is the author of The Impact of Nanotechnology in Drug Delivery: Global Developments.